How patients deal with an ambiguous medical test: Decision-making after genetic testing.

Decision-making Genetics Hereditary breast cancer Mental models Patient-provider communication Variant of uncertain significance

Journal

Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280

Informations de publication

Date de publication:
05 2021
Historique:
received: 31 03 2020
revised: 15 09 2020
accepted: 15 10 2020
pubmed: 21 11 2020
medline: 22 5 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

We know little about how patients make decisions when they receive a variant of uncertain significance result (VUS) from genetic testing. The purpose of this study was to elucidate a model of patient-informed decision-making after receiving a VUS result. Using an adapted Mental Models Approach, we conducted semi-structured interviews with women who received a VUS result from genetic testing for hereditary breast cancer (N = 20) to explore factors they believed were relevant to their decision-making. Two coders used a coding scheme informed by experts in hereditary breast cancer to conduct analysis. Inter-coder reliability was α = .86. Three overarching decision themes emerged from the interviews: managing ambiguity, medical risk management, and sharing results with others. While participants noted some difficulty understanding their result, genetic counselors' interpretations, psychosocial factors (e.g., risk perceptions), and competing extrinsic demands influenced their decisions. Complex influences affect patient decision-making after a VUS result from genetic testing and may encourage health protective behavior. Even patients who understand their test result could use support managing the ambiguity of their test result and sharing it with others.

Identifiants

pubmed: 33214013
pii: S0738-3991(20)30557-7
doi: 10.1016/j.pec.2020.10.020
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Pagination

953-959

Subventions

Organisme : NCI NIH HHS
ID : R03 CA194643
Pays : United States

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Courtney L Scherr (CL)

Department of Communication, Northwestern University, Chicago, IL, USA. Electronic address: courtney.scherr@northwestern.edu.

Sanjana Ramesh (S)

Department of Communication, Northwestern University, Chicago, IL, USA.

Hannah Getachew-Smith (H)

Department of Communication, Northwestern University, Chicago, IL, USA.

Kerstin Kalke (K)

Department of Communication, Northwestern University, Chicago, IL, USA.

Kyra Ramsey (K)

Department of Communication, Northwestern University, Chicago, IL, USA.

Baruch Fischhoff (B)

Engineering and Public Policy, Carnegie Mellon University, Pittsburgh, PA, USA.

Susan T Vadaparampil (ST)

Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH